An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... 2022 — Initial tests of a new 'crystal ball' for COPD revealed that it ...
Despite advancements in prenatal genetic screening, current medical technology cannot identify all genetic conditions in ...
Dr Tyagi says that diagnosing a brain blood clot requires a thorough medical evaluation, often involving advanced imaging techniques like CT scans or MRIs. These tests help pinpoint the location ...
Vinod Kambli in Hospital: Vinod Kambli has been admitted to a Thane hospital due to ill health. Medical reports have revealed blood clots in his brain, PTI reported. It added that Dr Vivek Trivedi, ...
Gunnar Esiason isn't like most hockey players -- his ability to complete a shift often depended on how his cystic fibrosis was affecting him that day. Throughout his journey with CF, hockey became ...
Gunnar Esiason isn't like most hockey players -- his ability to complete a shift often depended on how his cystic fibrosis was affecting him that day. Throughout his journey with CF, hockey became a ...
As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...
Cystic fibrosis (CF) is a genetic condition that ... and portal hypertension (high blood pressure in the liver’s veins). Liver disease affects about 5% to 10% of people with CF, typically ...
Vertex Pharmaceuticals said Friday the FDA has approved its next cystic fibrosis product Alyftrek, clearing the biotech to market a product designed to improve on Trikafta. William Blair analysts see ...
A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations that are eligible for Trikafta, as well as 31 other rare mutations that ...
The U.S. Food and Drug Administration (FDA) today approved the expansion of Trikafta (elexacaftor/tezacaftor/ivacaftor) to people with cystic fibrosis ages 2 and ...